Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Current therapeutic strategies of OA are largely concentrated in symptomatic management, such as oral non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular steroid injections, which only provide temporary relief 3,4
Routes Subcutaneous (SubQ) injection and topical formulations are the two main research-use routes
protects mitrochondria from oxidative damage
This modification increases stability against DPP-IV enzymatic degradation, significantly extending half-life in research models compared to native GHRH
Recently, a potent inhibitor of SLC1A5, V-9302, has been reported to be effective in several cancer cell lines and in vivo tumor models 205
Compared to the M1 macrophages that are pro-inflammatory and tumor suppressive, the anti-inflammatory and pro-tumor M2 macrophages are more abundant in tumors [184]
